BreachRx Announces 2026 Rex Awards Recognizing the Most Influential Leaders in Cyber Incident Response The Manila Times
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
